CAW
BMRN icon

Cornerstone Advisors (Washington)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,163
Closed -$100K – 907
2019
Q2 		$100K Buy
1,163
+45
+4% +$3.85K 0.01% 248
2019
Q1 		$99K Buy
1,118
+62
+6% +$5.75K 0.01% 232
2018
Q4 		$90K Sell
1,056
-2
-0.2% -$190 0.02% 202
2018
Q3 		$103K Hold
1,058
– – 0.07% 208
2018
Q2 		$100K Sell
1,058
-69
-6% -$6.04K 0.07% 201
2018
Q1 		$91K Hold
1,127
– – 0.06% 204
2017
Q4 		$100K Sell
1,127
-219
-16% -$19K 0.07% 187
2017
Q3 		$125K Sell
1,346
-4
-0.3% -$353 0.09% 167
2017
Q2 		$123K Sell
1,350
-25
-2% -$2.27K 0.07% 159
2017
Q1 		$121K Buy
1,375
+4
+0.3% +$356 0.07% 163
2016
Q4 		$114K Buy
1,371
+212
+18% +$18.2K 0.1% 158
2016
Q3 		$107K Buy
1,159
+209
+22% +$19.7K 0.09% 166
2016
Q2 		$74K Buy
950
+13
+1% +$1.1K 0.08% 125
2016
Q1 		$77K Buy
937
+104
+12% +$8.46K 0.08% 128
2015
Q4 		$87K Sell
833
-960
-54% -$100K 0.1% 128
2015
Q3 		$189K Sell
1,793
-275
-13% -$36.7K 0.17% 99
2015
Q2 		$283K Hold
2,068
– – 0.23% 72
2015
Q1 		$258K Hold
2,068
– – 0.2% 86
2014
Q4 		$187K Buy
+2,068
New +$172K 0.14% 116

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Cornerstone Advisors (Washington)'s BMRN Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2019, closing a stake of 1,163 shares — an estimated $100K sold.

Cornerstone Advisors (Washington) first reported a position in BMRN in Q4 2014 and held it in 19 quarters. The position peaked at $283K in Q2 2015. 436 funds tracked by Wall St. Rank hold BMRN as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining BioMarin Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 1,163 BioMarin Pharmaceuticals shares in Q3 2019, an estimated $100K.
  • Cornerstone Advisors (Washington) first reported a position in BioMarin Pharmaceuticals in Q4 2014 and held it in 19 quarters.
  • Cornerstone Advisors (Washington)'s BioMarin Pharmaceuticals position peaked at $283K in Q2 2015.
  • 436 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.